The Michael J. Fox Foundation Hosts First Clinical Trials Fair in Chicago
Event Aims to Educate on Local Opportunities to Join the Pursuit for a Cure
CHICAGO, Sept. 6, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its first Clinical Trials Fair in Chicago on September 7, 2013, to raise awareness and understanding of local Parkinson's research opportunities among patients, their families and friends, and other interested volunteers.
"We as patients and loved ones have to do something. We are the ones looking for answers, and if we don't raise our hands and start participating in clinical trials, we'll never get to a cure," said Parkinson's patient and trials fair panelist Claudia Revilla. "There are so many opportunities to get involved right here in our own backyard and today's event will feature many opportunities to play a critical role in research which will benefit the rest of the Parkinson's community and future generations."
Clinical trials are a critical step in bringing new treatments to the patients who need them, yet 85 percent are delayed and 30 percent never get off the ground due to a lack of participation, stalling the progress of potential therapies. Though 60 percent of people with Parkinson's disease (PD) say they are willing to participate in a clinical trial, fewer than 10 percent ever do.
In 2012, MJFF launched Fox Trial Finder (www.foxtrialfinder.org), an online platform that connects volunteers with and without PD to clinical trials in their area – increasing the efficiency of the enrollment process and empowering patients to get more involved in the discovery of new therapies.
At the Chicago Clinical Trials Fair, MJFF CEO Todd Sherer, PhD, will discuss the critical role that patients and their loved ones play in accelerating new therapies by participating in clinical research. Representatives from leading research centers in the surrounding area will also be present to provide information on 23 clinical trials recruiting locally. MJFF staff members and local Fox Trial Finder volunteers will be on site to answer questions about the Fox Trial Finder tool.
"We hope attendees will gain further knowledge about what it means to be a research trial participant and feel empowered to put that knowledge into action. Anyone who attends will have the opportunity to be able to connect with a trial that day or register on Fox Trial Finder to volunteer for other or future trial opportunities," said Claire Meunier, director of clinical trial strategies of MJFF.
The Chicago Clinical Trials Fair will take place from 8:30 a.m. to 1 p.m. at The Palmer House Hilton Hotel located at 17 East Monroe Street. The event is open to the public and includes free parking and refreshments. For more information, please visit www.michaeljfox.org/chicagotrialsfair. Several more MJFF Clinical Trial Fairs are planned for 2013 and 2014 around the country.
About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $350 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.
SOURCE The Michael J. Fox Foundation for Parkinson's Research